Drug-Resistant TB Threatens Global Control Efforts, Researchers Warn In Lancet Report

The Guardian: Decades of TB progress threatened by drug-resistant bacteria, warn experts
“The rise of multi-drug resistant bacteria threatens to overturn decades of progress on tuberculosis (TB), experts are warning. Multi-drug resistant (MDR) and extensively drug-resistant (XDR) strains of TB are causing increasing concern, says a new report in the Lancet Respiratory Medicine journal. Migration and travel mean that drug-resistant cases of tuberculosis that are difficult to treat have appeared in almost every part of the world…” (Boseley, 3/23).

Reuters: Rise of superbug tuberculosis hampers global control efforts
“…While some new antibiotics with the potential to treat some drug-resistant strains are becoming available for the first time, experts who conducted a global study said that without accurate diagnostics, better case tracking, and clear treatment guidelines, their effectiveness could rapidly be lost. ‘Resistance to anti-tuberculosis drugs is a global problem that threatens to derail efforts to eradicate the disease,’ said Keertan Dheda, a University of Cape Town professor who co-led research published in the Lancet Respiratory Medicine journal…” (Kelland, 3/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.